Dr. Lal Path Labs Share Price Today | Stock Price & Dr. Lal Path Labs Share Screener

Track the current stock price of Dr. Lal Path Labs with an interactive chart. Analyse LALPATHLAB share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Dr. Lal Path Labs stock quote in one place.

The quote of ₹1,843.70 sits between the 52-week low of ₹1,307.60 and the 52-week high of ₹3,254.90, and the latest session moved 0.41% from the previous close.

Screen Dr. Lal Path Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for LALPATHLAB shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare Services sector and the Healthcare Service Provider industry, with Arvind Lal listed as chairperson or CEO, and it trades under ISIN INE600L01024.

Dr Lal PathLabs is a leading diagnostic healthcare service provider in India. The company operates a nationwide network of medical laboratory centers, offering over 5000 diagnostic tests and related healthcare services. Its infrastructure includes a National Reference Laboratory in New Delhi, Regional Reference Labs in Kolkata, Bangalore, and Mumbai, 371...more

Classification

Identifiers and Leadership

Screen LALPATHLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹3,146, up from ₹2,717 in 2025.

Latest statistics put total assets at ₹3,146 and shareholder funds at ₹2,541, with a leverage ratio of 0.08.

Screen Dr. Lal Path Labs income statement and profit fundamentals. Analyze LALPATHLAB quarterly results. Dr. Lal Path Labs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹727 and net profit was ₹132, equal to earnings per unit of ₹7.86, at an operating margin of 27%.

In that period expenses were ₹516, interest cost ₹6 and tax ₹28. The next period listed, 2026-Jun, shows revenue of ₹830 and net profit of ₹171.

Screen LALPATHLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹636, and net cash flow was an outflow of ₹50.

Over the same period, investing activities used ₹422 and financing activities used ₹264.

See Dr. Lal Path Labs shareholding pattern with promoter, FII, and DII holdings. Check Dr. Lal Path Labs promoter holding and ownership changes for LALPATHLAB on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 52.93%, foreign institutions 18.73%, domestic institutions 21.58% and the public 5.30%, spread across 113,559 shareholders.

The shareholder count was 113,559 in 2026-Sept, compared with 111,037 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Dr. Lal Path Labs. Dr. Lal Path Labs dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹20.50 per unit for 2026-March, a yield of 1.11%, compared with ₹24.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹20.50, ₹24.00 and ₹24.00 per unit.

See which indices include Dr. Lal Path Labs stock. Check LALPATHLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 20 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX MSL400.

Get Dr. Lal Path Labs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Dr. Lal Path Labs stock events that may affect LALPATHLAB share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 4, 2026, with a record date of November 4, 2026.

It is followed by Dividend dated July 30, 2026 and Annual General Meeting dated July 25, 2026.

Screen LALPATHLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen LALPATHLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 17, 2026.

The next most recent announcements are dated October 16, 2026 and October 13, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 23, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.